FIGURE

Fig. 1

ID

ZDB-FIG-241206-1

Publication

Smith et al., 2024 - Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment

Other Figures

All Figure Page

Back to All Figure Page

Fig. 1

Acral melanoma (AM) tumors highly amplify and/or upregulate RTK adapter proteins, VEGFR, FGFR, and FGF ligands (A) From 88 tumors in the Wang 2023 cohort, the percentage of tumors bearing RTK-associated allele loss, (B) amplification, or (C) high copy-number amplification above 4x background tumor ploidy are shown. D In comparison to CM, AM highly express RTK and intracellular RTK adapters (CRKL and GAB2) per Weiss 2022 [6]. Certain ligands such as FGF3 and FGF19 were expressed at low levels in some AM tumors compared to lack of expression in CM. P-adjusted significance values are indicated as follows: ~ p = 0.05–0.07, * p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, † low expression gives error in p-value calculations. E Large insertion and deletion (InDel) events and (F) translocation events involving RTK-associated genes occur in a minority of AM per Liang 2017 [84] and Newell 2020 [4]. G A summary of published CNV and expression results for select genes are tabulated

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ J. Exp. Clin. Cancer Res.